OAZ2
Ornithine decarboxylase antizyme 2
Also known as: OAZ2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95190
- Gene
- OAZ2
- Ensembl
- ENSG00000180304
- Chromosome
- 15
- Canonical length
- 189 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the ornithine decarboxylase antizyme family, which plays a role in cell growth and proliferation by regulating intracellular polyamines. Expression of antizymes requires +1 ribosomal frameshifting, which is enhanced by high levels of polyamines. Antizymes in turn bind to and inhibit ornithine decarboxylase (ODC), the key enzyme in polyamine biosynthesis; thus, completing the auto-regulatory circuit. This gene encodes antizyme 2, the second member of the antizyme family. Like antizyme 1, antizyme 2 has broad tissue distribution, inhibits ODC activity and polyamine uptake, and stimulates ODC degradation in vivo; however, it fails to promote ODC degradation in vitro. Antizyme 2 is expressed at lower levels than antizyme 1, but is evolutionary more conserved, suggesting it likely has an important biological role. Studies also show different subcellular localization of antizymes 1 and 2, indicating specific function for each antizyme in discrete compartments of the cell. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
189 residues, UniProt reviewed canonical sequence.
>O95190|OAZ2
1 MINTQDSSIL PLSNCPQLQC CRHIVPGPLW CSDAPHPLSK IPGGRGGGRD PSLSALIYKD
61 EKLTVTQDLP VNDGKPHIVH FQYEVTEVKV SSWDAVLSSQ SLFVEIPDGL LADGSKEGLL
121 ALLEFAEEKM KVNYVFICFR KGREDRAPLL KTFSFLGFEI VRPGHPCVPS RPDVMFMVYP
181 LDQNLSDEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OAZ2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 195 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 195 nTPM
- tongue: 142 nTPM
- retina: 114 nTPM
- cerebral cortex: 110 nTPM
- amygdala: 110 nTPM
- midbrain: 106 nTPM
Single-cell type
- early spermatids: 400 nCPM
- neutrophils: 290 nCPM
- late primary spermatocytes: 174 nCPM
- müller glia: 169 nCPM
- early primary spermatocytes: 168 nCPM
- epicardial cells: 164 nCPM
Immune cell
- neutrophil: 420 nTPM
- eosinophil: 269 nTPM
- intermediate monocyte: 248 nTPM
- non-classical monocyte: 211 nTPM
- classical monocyte: 146 nTPM
- total PBMC: 116 nTPM
Brain region
- midbrain: 78 nTPM
- thalamus: 78 nTPM
- white matter: 78 nTPM
- hypothalamus: 77 nTPM
- spinal cord: 76 nTPM
- medulla oblongata: 74 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0.31
- gnomAD missense Z
- 1.27
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of polyamine transmembrane transport
- polyamine biosynthetic process
- polyamine metabolic process
- positive regulation of intracellular protein transport
- positive regulation of protein catabolic process
- viral translational frameshifting
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OAZ2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OAZ2 as an antibody target. Whether an autoantibody or antibody against OAZ2 could matter depends on whether native OAZ2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OAZ2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OAZ2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...